Today: 20 May 2026
BitMine Immersion (BMNR) stock ends higher after $14.5B crypto holdings update as market looks to next session
22 January 2026
2 mins read

BitMine Immersion (BMNR) stock ends higher after $14.5B crypto holdings update as market looks to next session

New York, January 21, 2026, 20:47 EST — Market closed

  • BitMine Immersion shares ended the day 3.9% higher at $29.35, holding steady in after-hours trading
  • The company reported total crypto and cash assets hit $14.5 billion, driven mainly by 4.203 million ether holdings
  • Shareholders gave the green light to a steep increase in authorized shares, a major point of interest for traders ahead of Thursday

Shares of BitMine Immersion Technologies Inc (BMNR) rose 3.9% on Wednesday, closing at $29.35 following the company’s update on the scale of its crypto and cash reserves. The stock inched higher in late after-hours trading.

The numbers are significant because BitMine is behaving more like a leveraged proxy for ether — the cryptocurrency behind the Ethereum blockchain — instead of a typical miner or hosting business. When ether’s price moves, the company’s net asset value often shifts in tandem, dragging the stock along with it.

This week’s update also intensified a second debate about the company’s method for funding additional token purchases. Shareholders approved a significant boost in authorized shares, allowing the company to issue more stock amid growing investor concerns about dilution.

As of Jan. 19 at 5 p.m. ET, BitMine reported holding 4,203,036 ether, each worth $3,211, along with 193 bitcoin. The company also has $979 million in cash and a $22 million stake in Eightco Holdings, which it calls a “moonshot.” Chairman Thomas “Tom” Lee noted, “In the past week, we acquired 35,268 ETH.” BitMine said the previously announced $200 million investment in Beast Industries is set to close this week.

BitMine revealed it has staked 1,838,003 ether, aiming to earn yield on its token holdings. The company pointed to a combined Ethereum staking rate of 2.81% as it prepares to launch its MAVAN staking network in the first quarter. Staking involves locking crypto to validate blockchain transactions in return for rewards.

A filing dated Jan. 20 revealed shareholders gave the green light to a charter amendment increasing authorized common shares from 500 million to 50 billion. The change took effect on Jan. 16 for accounting purposes. That meeting also addressed director elections and other governance matters, the filing indicated.

Ether hovered near $3,015, with bitcoin close to $89,928. Both gained ground during the session, providing a more stable backdrop for crypto-linked stocks heading into Thursday.

BitMine positions itself alongside other listed crypto “treasury” plays and miners that investors treat as liquid proxies for tokens. The company has singled out Strategy Inc. (MSTR) as a key reference in the crypto-treasury arena. Meanwhile, miners like Marathon Digital and Riot Platforms tend to join the same momentum swings when crypto prices shift.

But the setup works both ways. A steep fall in ether would dent the marked value of BitMine’s holdings, while staking returns aren’t guaranteed—they can shift as network conditions evolve. Any hiccup in launching its validator network could stall the yield narrative. On top of that, the expanded share authorization keeps investors alert for fresh issuance, which might weigh on the stock despite funding further token buys.

Traders eye Thursday’s session for a filing that confirms the Beast Industries deal is done, along with clues on BitMine’s timeline for using its expanded share capacity. After that, focus moves to the upcoming MAVAN launch slated for the first quarter and the company’s next update on holdings.

Stock Market Today

  • Sea Limited (NYSE:SE) Valuation Under Scrutiny After 46% One-Year Share Decline
    May 20, 2026, 10:05 AM EDT. Sea Limited (NYSE:SE), active across e-commerce, digital financial services, and digital entertainment in Southeast Asia and Latin America, has seen its stock fall by 46.26% over the past year. Despite recent share price weakness, some analysts argue the stock trades 36.6% below a $137.64 fair value estimate, buoyed by strong revenue growth from Shopee, Monee, and Garena platforms. Key drivers include accelerating mobile internet penetration, youth digital literacy, and shifts toward cashless payments supporting loan book expansion and improved monetization. Market watchers debate whether this dip offers a buying opportunity or reflects tempered growth prospects, especially as Shopee faces competitive pressures. Investors should weigh Sea's potential for earnings growth against market realities and execution risks.

Latest articles

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

20 May 2026
Vida Global Inc. raised $15 million in its May 18 IPO, selling 3.75 million shares at $4 each, but the stock closed at $2.29 on Tuesday. CEO Lyle Pratt bought 312,900 shares for about $1.19 million, according to a Form 4 filing. Vida reported 2025 revenue of $551,383 and a net loss of $2.9 million. The company’s shares trade on NYSE American and NYSE Texas under the symbol VIDA.
TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

20 May 2026
TJX raised its fiscal 2027 sales, earnings, and buyback targets after first-quarter comparable sales rose 6% and net income hit $1.3 billion. Shares climbed 3.6% in premarket trading. The company cited higher fuel costs as a drag on its full-year forecast. Marmaxx, HomeGoods, and TJX Canada all posted strong sales growth.
ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio Faces FDA Decision on Bladder-Cancer Application, Risk Remains

20 May 2026
The FDA accepted ImmunityBio’s application to expand Anktiva’s use with BCG in papillary-only, BCG-unresponsive non-muscle invasive bladder cancer, setting a Jan. 6, 2027 decision date. ImmunityBio reported $44.2 million in first-quarter net product revenue and held $380.9 million in cash and equivalents. Shares last traded at $7.76, down 2.8%. The filing is supported by data from 80 patients in a Phase 2/3 trial.
Applied Digital stock slides, then swings hard as new Buy call pegs $42 target — what’s next for APLD
Previous Story

Applied Digital stock slides, then swings hard as new Buy call pegs $42 target — what’s next for APLD

Compass Group shares rise in early London trade: what the CPG stock price move says ahead of Feb 5 update
Next Story

Compass Group shares rise in early London trade: what the CPG stock price move says ahead of Feb 5 update

Go toTop